(DSFIR) DSM-Firmenich - Ratings and Ratios
Exchange: AS • Country: Switzerland • Currency: EUR • Type: Common Stock • ISIN: CH1216478797
DSFIR: Fragrances, Beauty, Flavors, Ingredients, Supplements, Animal Nutrition
DSM-Firmenich AG is a global leader in nutrition, health, and beauty solutions, operating across multiple regions including Switzerland, the Netherlands, Europe, the Middle East, Africa, North America, Latin America, China, and Asia. The company is organized into four key segments: Perfumery & Beauty, Taste, Texture & Health, Health, Nutrition & Care, and Animal Nutrition & Health. The Perfumery & Beauty segment specializes in creating fragrances using advanced natural, synthetic, and biotechnological ingredients. The Taste, Texture & Health segment offers comprehensive food and beverage solutions, including flavor enhancement, natural extracts, and sugar reduction technologies, alongside food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for early life nutrition, dietary supplements, pharmaceuticals, medical nutrition, biomedical materials, and nutrition improvement. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics, prebiotics, and active pharmaceutical ingredients, as well as biomedical solutions, premix, market-ready, and personalized nutrition solutions, complemented by expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment focuses on animal proteins, vitamins, performance solutions, and data-driven precision services. Founded in 1902, the company is headquartered in Kaiseraugst, Switzerland.
DSM-Firmenich AG is recognized for its commitment to innovation and sustainability, leveraging cutting-edge technologies to address global challenges in nutrition, health, and beauty. The companys extensive portfolio caters to diverse markets, from human nutrition to animal health, ensuring a comprehensive approach to wellness and sustainability.
Additional Sources for DSFIR Stock
DSFIR Stock Overview
| Market Cap in USD | 28,529m |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| GiC Sub-Industry | Personal Care Products |
| IPO / Inception |
DSFIR Stock Ratings
| Growth Rating | -28.9 |
| Fundamental | -30.7 |
| Dividend Rating | 30.7 |
| Rel. Strength | -3.07 |
| Analysts | - |
| Fair Price Momentum | 80.23 EUR |
| Fair Price DCF | 46.33 EUR |
DSFIR Dividends
| Dividend Yield 12m | 1.58% |
| Yield on Cost 5y | 1.40% |
| Annual Growth 5y | 25.00% |
| Payout Consistency | 100.0% |
DSFIR Growth Ratios
| Growth Correlation 3m | -66.2% |
| Growth Correlation 12m | -68.3% |
| Growth Correlation 5y | 30.3% |
| CAGR 5y | -7.42% |
| CAGR/Max DD 5y | -0.21 |
| Sharpe Ratio 12m | -1.55 |
| Alpha | -17.11 |
| Beta | 0.318 |
| Volatility | 24.80% |
| Current Volume | 506.4k |
| Average Volume 20d | 437k |
As of May 09, 2025, the stock is trading at EUR 93.76 with a total of 506,365 shares traded.
Over the past week, the price has changed by +1.36%, over one month by +10.63%, over three months by +0.39% and over the past year by -8.14%.
Probably not. Based on ValueRay Fundamental Analyses, DSM-Firmenich (AS:DSFIR) is currently (May 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -30.70 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DSFIR as of May 2025 is 80.23. This means that DSFIR is currently overvalued and has a potential downside of -14.43%.
DSM-Firmenich has no consensus analysts rating.
According to ValueRays Forecast Model, DSFIR DSM-Firmenich will be worth about 87.6 in May 2026. The stock is currently trading at 93.76. This means that the stock has a potential downside of -6.6%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 122.7 | 30.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 87.6 | -6.6% |